<VariationArchive RecordType="classified" VariationID="30259" VariationName="NM_005506.4(SCARB2):c.1187+2dup" VariationType="Duplication" Accession="VCV000030259" Version="8" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2023-02-13" DateCreated="2015-10-11" MostRecentSubmission="2023-02-07">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="39215" VariationID="30259">
      <GeneList>
        <Gene Symbol="SCARB2" FullName="scavenger receptor class B member 2" GeneID="950" HGNC_ID="HGNC:1665" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>4q21.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="4" Accession="NC_000004.12" start="76158737" stop="76234532" display_start="76158737" display_stop="76234532" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="4" Accession="NC_000004.11" start="77079889" stop="77135051" display_start="77079889" display_stop="77135051" Strand="-" />
          </Location>
          <OMIM>602257</OMIM>
          <Haploinsufficiency last_evaluated="2012-07-06" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SCARB2">No evidence available</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2012-07-06" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SCARB2">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_005506.4(SCARB2):c.1187+2dup</Name>
      <CanonicalSPDI>NC_000004.12:76168400:A:AA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>4q21.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="4" Accession="NC_000004.12" start="76168400" stop="76168401" display_start="76168400" display_stop="76168401" variantLength="1" positionVCF="76168400" referenceAlleleVCF="T" alternateAlleleVCF="TA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="4" Accession="NC_000004.11" start="77089553" stop="77089554" display_start="77089553" display_stop="77089554" variantLength="1" positionVCF="77089553" referenceAlleleVCF="T" alternateAlleleVCF="TA" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000004.11" sequenceAccession="NC_000004" sequenceVersion="11" change="g.77089554dup" Assembly="GRCh37">
            <Expression>NC_000004.11:g.77089554dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000004.12" sequenceAccession="NC_000004" sequenceVersion="12" change="g.76168401dup" Assembly="GRCh38">
            <Expression>NC_000004.12:g.76168401dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_012054.1" sequenceAccession="NG_012054" sequenceVersion="1" change="g.50482dup">
            <Expression>NG_012054.1:g.50482dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001204255.2" sequenceAccession="NM_001204255" sequenceVersion="2" change="c.758+2dup">
            <Expression>NM_001204255.2:c.758+2dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_005506.4" sequenceAccession="NM_005506" sequenceVersion="4" change="c.1187+2dup" MANESelect="true">
            <Expression>NM_005506.4:c.1187+2dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_005506.3" sequenceAccession="NM_005506" sequenceVersion="3" change="c.1187+3insT">
            <Expression>NM_005506.3:c.1187+3insT</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA213020" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="602257.0007" DB="OMIM" />
        <XRef Type="rs" ID="727502783" DB="dbSNP" />
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00001" Source="Exome Aggregation Consortium (ExAC)" />
        <AlleleFrequency Value="0.00008" Source="NHLBI Exome Sequencing Project (ESP) Exome Variant Server" />
        <AlleleFrequency Value="0.00001" Source="The Genome Aggregation Database (gnomAD), exomes" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_005506.4(SCARB2):c.1187+2dup AND Action myoclonus-renal failure syndrome" Accession="RCV000023185" Version="5">
        <ClassifiedConditionList TraitSetID="2008">
          <ClassifiedCondition DB="MedGen" ID="C0751779">Action myoclonus-renal failure syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2015-03-05" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_005506.4(SCARB2):c.1187+2dup AND Progressive myoclonic epilepsy" Accession="RCV001203978" Version="6">
        <ClassifiedConditionList TraitSetID="13597">
          <ClassifiedCondition DB="MedGen" ID="C0751778">Progressive myoclonic epilepsy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-08-29" SubmissionCount="1">Uncertain significance</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-08-29" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2015-10-11" MostRecentSubmission="2023-02-07">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Uncertain significance</Description>
        <Citation Type="review" Abbrev="GeneReviews">
          <ID Source="PubMed">26677510</ID>
          <ID Source="BookShelf">NBK333437</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">17576681</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21670406</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9536098</ID>
        </Citation>
        <DescriptionHistory Dated="2022-08-22">
          <Description>Conflicting classifications of pathogenicity</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2022-08-07">
          <Description>Uncertain significance</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2020-07-15">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="13597" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3141" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Myoclonus epilepsy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Progressive myoclonus epilepsy</ElementValue>
                <XRef ID="MONDO:0020074" DB="MONDO" />
                <XRef ID="267581004" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Familial progressive myoclonic epilepsy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Myoclonic Epilepsies, Progressive</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Progressive myoclonic epilepsy</ElementValue>
                <XRef ID="Progressive+myoclonic+epilepsy/9622" DB="Genetic Alliance" />
                <XRef ID="267581004" DB="SNOMED CT" />
              </Name>
              <XRef ID="308" DB="Orphanet" />
              <XRef ID="98261" DB="Orphanet" />
              <XRef ID="C0751778" DB="MedGen" />
              <XRef ID="MONDO:0020074" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS254800" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="2008" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="25" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Action myoclonus-renal failure syndrome</ElementValue>
                <XRef ID="MONDO:0009699" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH RENAL FAILURE</ElementValue>
                <XRef Type="Allelic variant" ID="602257.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="602257.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="602257.0002" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITHOUT RENAL FAILURE</ElementValue>
                <XRef Type="Allelic variant" ID="602257.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="602257.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="602257.0006" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MYOCLONUS-NEPHROPATHY SYNDROME</ElementValue>
                <XRef Type="MIM" ID="254900" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Epilepsy, progressive myoclonic 4, with or without renal failure</ElementValue>
                <XRef ID="Epilepsy%2C+progressive+myoclonic+4%2C+with+or+without+renal+failure/8334" DB="Genetic Alliance" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">AMRF</ElementValue>
                <XRef Type="MIM" ID="254900" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">EPM4</ElementValue>
                <XRef Type="MIM" ID="254900" DB="OMIM" />
              </Symbol>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">26677510</ID>
                <ID Source="BookShelf">NBK333437</ID>
              </Citation>
              <XRef ID="163696" DB="Orphanet" />
              <XRef ID="C0751779" DB="MedGen" />
              <XRef ID="D020191" DB="MeSH" />
              <XRef ID="MONDO:0009699" DB="MONDO" />
              <XRef Type="MIM" ID="254900" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="628587" SubmissionDate="2015-03-05" DateLastUpdated="2015-10-11" DateCreated="2015-10-11">
        <ClinVarSubmissionID localKey="NM_005506.3:c.1187+3insT|OMIM:254900" submittedAssembly="not applicable" />
        <ClinVarAccession Accession="SCV000328640" DateUpdated="2015-10-11" DateCreated="2015-10-11" Type="SCV" Version="1" SubmitterName="GeneReviews" OrgID="500062" OrganizationCategory="resource" OrgAbbreviation="GeneReviews" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2015-03-05">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">21670406</ID>
          </Citation>
          <Citation>
            <URL>http://www.ncbi.nlm.nih.gov/books/NBK333437/</URL>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SCARB2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_005506.3:c.1187+3insT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="254900" Type="MIM" />
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="49732" SubmissionDate="2018-06-21" DateLastUpdated="2018-06-25" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="602257.0007_EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITHOUT RENAL FAILURE" title="SCARB2, 1-BP INS, T, IVS9_EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITHOUT RENAL FAILURE" />
        <ClinVarAccession Accession="SCV000044476" DateUpdated="2018-06-25" DateCreated="2013-04-04" Type="SCV" Version="4" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2011-06-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">For discussion of the 1187+3insT mutation that was found in compound heterozygous state in a patient with progressive myoclonic epilepsy-4 (EPM4; 254900) by Dibbens et al. (2011), see 602257.0003.</Attribute>
              <Citation>
                <ID Source="PubMed">21670406</ID>
              </Citation>
              <XRef DB="OMIM" ID="254900" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SCARB2" />
          </GeneList>
          <Name>SCARB2, 1-BP INS, T, IVS9</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP INS, T, IVS9</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="602257.0007" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITHOUT RENAL FAILURE</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2709889" SubmissionDate="2023-01-06" DateLastUpdated="2023-02-07" DateCreated="2020-07-16">
        <ClinVarSubmissionID localKey="4850131|MedGen:C0751778" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001375163" DateUpdated="2023-02-07" DateCreated="2020-07-16" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-08-29">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Uncertain significance</GermlineClassification>
          <Citation>
            <ID Source="PubMed">21670406</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17576681</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9536098</ID>
          </Citation>
          <Comment>This sequence change falls in intron 9 of the SCARB2 gene. It does not directly change the encoded amino acid sequence of the SCARB2 protein. It affects a nucleotide within the consensus splice site. This variant is present in population databases (rs727502783, gnomAD 0.002%). This variant has been observed in individual(s) with progressive myoclonic epilepsy without renal failure (PMID: 21670406). This variant is also known as c.1187+3insT. ClinVar contains an entry for this variant (Variation ID: 30259). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SCARB2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000004.11:g.77089553_77089554insA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0751778" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="49732" TraitType="Disease" MappingType="Name" MappingValue="EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITHOUT RENAL FAILURE" MappingRef="Preferred">
        <MedGen CUI="C0751779" Name="Action myoclonus-renal failure syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="628587" TraitType="Disease" MappingType="XRef" MappingValue="254900" MappingRef="OMIM">
        <MedGen CUI="C0751779" Name="Action myoclonus-renal failure syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2709889" TraitType="Disease" MappingType="XRef" MappingValue="C0751778" MappingRef="MedGen">
        <MedGen CUI="C0751778" Name="Progressive myoclonic epilepsy" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

